Dow Up 2.00% Nasdaq Up 1.66%

GlycoMimetics, Inc. (GLYC)

-NasdaqGM
3.91 Up 0.10(2.62%) Feb 12, 3:54PM EST
Prev Close:3.81
Open:3.83
Bid:N/A
Ask:5.75 x 1000
1y Target Est:13.33
Beta:N/A
Earnings Date:Mar 14 - Mar 18 (Est.)
Day's Range:3.78 - 4.08
52wk Range:3.70 - 9.22
Volume:1,298
Avg Vol (3m):20,536
Market Cap:74.44M
P/E (ttm):N/A
EPS (ttm):-0.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GLYC

Comparison

Symbol% ChgMkt Cap
GLYCUp 2.62%74.44M
BMYUp 1.14%100.43B
MSTXUp 8.72%41.82M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):3.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.64
Quarterly EPS Est (Dec-15) :-0.43
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlycoMimetics, Inc., a clinical stage biotechnology company, focuses on the discovery and development of glycomimetic drugs to address unmet medical needs resulting from diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback